Immunic (IMUX) Current Assets (2013 - 2026)

Immunic has reported Current Assets for 14 years, with the latest figure at $188.8 million in Q1 2026.

• Quarterly Current Assets rose 894.78% year-over-year to $188.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.8 million (up 894.78% YoY) and the FY2025 annual result came in at $22.9 million, down 41.86% from the prior year.
• Current Assets climbed to $188.8 million in Q1 2026 per IMUX's latest filing, from $22.9 million in the prior quarter.
• Over five years, Current Assets peaked at $188.8 million in Q1 2026 and troughed at $19.0 million in Q1 2025.
• A 5-year average of $80.2 million and a median of $85.0 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2025 and 2026: Current Assets sank 81.51% in 2025, then soared 894.78% in 2026.
• Over 5 years, Current Assets stood at $125.9 million in 2022, then tumbled by 58.26% to $52.5 million in 2023, then decreased by 25.13% to $39.3 million in 2024, then sank by 41.86% to $22.9 million in 2025, then soared by 725.39% to $188.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $188.8 million, $22.9 million, and $39.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.